Alkermes
ALKS
#3093
Rank
S$6.31 B
Marketcap
S$38.25
Share price
0.75%
Change (1 day)
-9.33%
Change (1 year)

Alkermes (ALKS) - Cash on Hand

Cash on Hand as of September 2025 : S$1.43 Billion

According to Alkermes's latest financial reports the company has S$1.43 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alkermes - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$1.02 B0.02%
2023-12-31S$1.02 B25.23%
2022-12-31S$0.81 B12.5%
2021-12-31S$0.72 B-13.7%
2020-12-31S$0.84 B16.48%
2019-12-31S$0.72 B-2.11%
2018-12-31S$0.73 B27.07%
2017-12-31S$0.57 B-19.43%
2016-12-31S$0.71 B-4.87%
2015-12-31S$0.75 B-9.3%
2014-12-31S$0.83 B
2013-03-31S$0.27 B14.78%
2012-03-31S$0.23 B-5.66%
2011-03-31S$0.25 B-35.48%
2010-03-31S$0.39 B-20.03%
2009-03-31S$0.49 B4.44%
2008-03-31S$0.47 B-11.75%
2007-03-31S$0.53 B10%
2006-03-31S$0.48 B44.34%
2005-03-31S$0.33 B39.7%
2004-03-31S$0.24 B0.07%
2003-03-31S$0.24 B-14.56%
2002-03-31S$0.28 B-39.22%
2001-03-31S$0.46 B-20.17%
2000-03-31S$0.57 B105.39%
1999-03-31S$0.28 B-10.08%
1998-03-31S$0.31 B154.78%
1997-03-31S$0.12 B170.49%
1996-03-31S$45.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Acorda Therapeutics
ACOR
S$12.13 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 1,385.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.05 B 1,570.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 1,248.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$10.60 B 636.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$2.85 B 98.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$13.54 B 840.67%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
S$12.63 B 777.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland